Tibet Duo Rui Pharmaceutical
301075
Alnera Aluminium
301613
ChengDu Sheng Nuo Biotec
688117
4
THEC
833509
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 16.78%10.5B | 21.04%7.7B | 17.85%5.02B | 16.20%2.32B | 1.32%8.99B | -2.66%6.36B | 0.67%4.26B | 6.82%2B | 14.27%8.88B | 16.31%6.54B |
Operating revenue | 16.78%10.5B | 21.04%7.7B | 17.85%5.02B | 16.20%2.32B | 1.32%8.99B | -2.66%6.36B | 0.67%4.26B | 6.82%2B | 14.27%8.88B | 16.31%6.54B |
Other operating revenue | 76.56%101.48M | ---- | -5.56%10.14M | ---- | 48.47%57.47M | ---- | -28.43%10.74M | ---- | -21.09%38.71M | ---- |
Total operating cost | 14.84%9.69B | 19.04%7.07B | 15.24%4.58B | 11.27%2.12B | 2.37%8.44B | -1.77%5.94B | 0.58%3.97B | 6.54%1.91B | 15.74%8.25B | 21.36%6.04B |
Operating cost | 15.78%8.09B | 18.53%5.87B | 14.36%3.82B | 13.56%1.77B | -1.42%6.99B | -6.55%4.96B | -2.44%3.34B | 3.02%1.56B | 15.91%7.09B | 22.36%5.3B |
Operating tax surcharges | 21.06%67.14M | 28.14%45.36M | 24.27%29.87M | 37.28%14.92M | -6.62%55.46M | 6.89%35.4M | 14.11%24.03M | 0.90%10.87M | 104.43%59.39M | 78.98%33.11M |
Operating expense | 17.65%379.25M | 24.49%271.23M | 26.39%180.79M | 33.25%81.05M | 23.89%322.34M | 16.55%217.87M | 14.26%143.03M | 5.84%60.82M | 24.75%260.18M | 49.21%186.92M |
Administration expense | -8.43%401.42M | -7.77%277.3M | -5.40%190.59M | -8.52%85.15M | 18.64%438.36M | 17.74%300.67M | 25.22%201.47M | 28.81%93.09M | 43.03%369.5M | 68.86%255.36M |
Financial expense | -1.72%-52.6M | 133.70%18.71M | 43.56%-28.78M | -122.63%-10.53M | 58.02%-51.71M | 66.24%-55.51M | 19.84%-50.99M | 160.49%46.54M | -293.11%-123.17M | -346.12%-164.43M |
-Interest expense (Financial expense) | 23.90%47.19M | 38.93%39.27M | 47.29%28.86M | 62.77%14.55M | 8.01%38.09M | 9.55%28.27M | 33.82%19.6M | 15.11%8.94M | 42.89%35.26M | 155.82%25.8M |
-Interest Income (Financial expense) | -1.04%-36.97M | -10.53%-25.21M | 2.51%-15.33M | 19.04%-6.38M | -59.29%-36.59M | -100.89%-22.81M | -142.37%-15.72M | -169.99%-7.88M | -163.33%-22.97M | -79.92%-11.36M |
Research and development | 17.25%809.01M | 20.31%580.82M | 22.46%388.54M | 32.14%182.43M | 16.48%689.97M | 12.34%482.76M | 11.39%317.29M | 15.44%138.06M | 31.65%592.35M | 51.03%429.72M |
Credit Impairment Loss | -578.90%-20.5M | -165.21%-6.21M | -202.13%-7.18M | -121.72%-2.37M | 93.88%-3.02M | 239.76%9.53M | 78.21%-2.38M | 161.87%10.9M | 42.32%-49.37M | 55.65%-6.82M |
Asset Impairment Loss | -13.33%-80.13M | -5.22%-48.88M | 10.88%-21.09M | 39.69%-9.37M | -1.07%-70.71M | 33.81%-46.45M | 49.00%-23.67M | 12.63%-15.54M | 30.04%-69.96M | 40.33%-70.18M |
Other net revenue | -278.94%-31.84M | 52.20%-14.12M | 61.82%-7.41M | -167.59%-1.61M | -226.87%-8.4M | -206.89%-29.55M | -90.89%-19.41M | -90.61%2.38M | 134.34%6.62M | 179.85%27.64M |
Fair value change income | -147.47%-5.95M | ---- | ---- | ---- | -85.73%12.54M | -125.73%-20.65M | -119.12%-6.04M | ---- | 2.51%87.82M | -8.26%80.26M |
Invest income | 135.12%3.95M | 204.97%2.86M | 162.44%2.03M | -5,930.86%-835.58K | -2,088.74%-11.23M | -119.25%-2.73M | -160.02%-3.24M | 98.39%-13.86K | -98.97%564.91K | -103.29%-1.24M |
Net open hedge income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Including: Investment income associates | 7.52%1.21M | 311.09%1.85M | 85.82%-133.54K | 70.22%-133.54K | 143.85%1.13M | 58.53%-875.42K | 56.04%-941.73K | 55.50%-448.38K | 10.92%-2.57M | 2.70%-2.11M |
Exchange income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Asset deal income | -88.62%-2.69M | -217.10%-4.56M | -101.64%-2.58M | 15.91%-317.88K | 11.57%-1.43M | -20.24%-1.44M | -349.60%-1.28M | -44.34%-378.01K | -298.79%-1.61M | -103.85%-1.2M |
Other revenue | 12.28%73.49M | 32.55%42.67M | 24.55%21.41M | 52.06%11.29M | 67.03%65.45M | 20.02%32.19M | 0.71%17.19M | -12.79%7.42M | 49.51%39.18M | 47.83%26.82M |
Operating profit | 42.91%776.26M | 56.51%618.02M | 62.91%430.16M | 116.20%193.68M | -14.63%543.19M | -23.94%394.88M | -1.49%264.04M | -12.53%89.58M | 2.04%636.24M | -19.94%519.17M |
Add:Non operating Income | 60.53%10.88M | -47.48%3.27M | -62.12%1.74M | -59.29%436.33K | 6.88%6.78M | 44.58%6.24M | 297.86%4.59M | 132.85%1.07M | 180.64%6.34M | 118.99%4.31M |
Less:Non operating expense | -42.12%12.32M | 11.98%12.33M | 30.89%5.56M | 132.31%2.77M | 128.59%21.28M | 88.94%11.01M | 36.31%4.25M | 17.18%1.19M | 68.10%9.31M | 39.58%5.83M |
Total profit | 46.56%774.82M | 56.10%608.96M | 61.26%426.34M | 113.88%191.34M | -16.52%528.68M | -24.64%390.1M | -0.63%264.38M | -12.17%89.46M | 2.10%633.28M | -19.90%517.66M |
Less:Income tax cost | 515.07%102.94M | 284.30%56.13M | 508.54%36.78M | 348.73%17.5M | -67.24%16.74M | -74.82%14.61M | -65.69%6.04M | -197.13%-7.04M | 6.14%51.08M | -17.92%58M |
Net profit | 31.24%671.88M | 47.23%552.83M | 50.79%389.56M | 80.16%173.84M | -12.07%511.95M | -18.31%375.5M | 3.98%258.34M | 1.98%96.5M | 1.76%582.2M | -20.14%459.66M |
Net profit from continuing operation | 31.24%671.88M | 47.23%552.83M | 50.79%389.56M | 80.16%173.84M | -12.07%511.95M | -18.31%375.5M | 3.98%258.34M | 1.98%96.5M | 1.76%582.2M | -20.14%459.66M |
Less:Minority Profit | 112.39%441.92K | 167.97%610.15K | 145.56%729.47K | -1,322.63%-1.79M | -343.12%-3.57M | -241.56%-897.72K | -83.47%297.07K | -42.84%146.75K | -111.26%-804.6K | -93.73%634.17K |
Net profit of parent company owners | 30.25%671.44M | 46.71%552.22M | 50.68%388.83M | 82.29%175.64M | -11.58%515.51M | -18.00%376.4M | 4.62%258.04M | 2.11%96.35M | 3.19%583M | -18.83%459.02M |
Earning per share | ||||||||||
Basic earning per share | 34.15%0.55 | 46.67%0.44 | 55.00%0.31 | 75.00%0.14 | -10.87%0.41 | -16.67%0.3 | 0.00%0.2 | 14.29%0.08 | -2.13%0.46 | -25.00%0.36 |
Diluted earning per share | 34.15%0.55 | 46.67%0.44 | 55.00%0.31 | 75.00%0.14 | -10.87%0.41 | -16.67%0.3 | 0.00%0.2 | 14.29%0.08 | -2.13%0.46 | -23.40%0.36 |
Other composite income | -316.59%-44.21M | -274.22%-35.5M | -155.92%-33.94M | -354.40%-11.23M | -75.51%20.41M | -71.25%20.38M | 234.32%60.69M | 122.75%4.41M | 223.89%83.35M | 934.08%70.89M |
Other composite income of parent company owners | -316.59%-44.21M | -274.22%-35.5M | -155.92%-33.94M | -354.40%-11.23M | -75.51%20.41M | -71.25%20.38M | 234.32%60.69M | 122.75%4.41M | 223.89%83.35M | 934.08%70.89M |
Total composite income | 17.90%627.68M | 30.68%517.33M | 11.47%355.62M | 61.15%162.62M | -20.01%532.36M | -25.38%395.88M | 19.66%319.03M | 34.15%100.91M | 31.83%665.55M | -6.45%530.54M |
Total composite income of parent company owners | 17.04%627.23M | 30.23%516.72M | 11.34%354.89M | 63.17%164.41M | -19.57%535.93M | -25.12%396.77M | 20.36%318.73M | 34.41%100.76M | 33.89%666.35M | -4.86%529.91M |
Total composite income of minority owners | 112.39%441.92K | 167.97%610.15K | 145.56%729.47K | -1,322.63%-1.79M | -343.12%-3.57M | -241.56%-897.72K | -83.47%297.07K | -42.84%146.75K | -111.26%-804.6K | -93.73%634.17K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.